Cancer context guide
You do not need to know the exact subtype. Use this short guide to carry useful context into the access request, or use the full 209-entry search below if you know the exact cancer type.
This avoids showing every subtype before the user is ready.
Selected context
Cancer area: Breast · Disease setting: Unsure · Marker/subtype guide: Not sure
Oncology intelligence
BioAtlas Oncology is a public-safe overview of cancer intelligence across hallmarks, subtypes, programmed cell death context, immune environment, metabolic adaptation, tissue behaviour, and pharma / biotech relevance.
Request reviewed accessHallmark Intelligence
BioAtlas organises 24 canonical hallmark datasets into a six-group hallmark architecture with context weighting, metabolic bridges, programmed cell death context, pathway pressure, immune escape, tissue behaviour, and governed review. The oncology page keeps the bridge visible, while the dedicated Hallmark Intelligence route explains the layer in its own right.
24
canonical hallmark datasets
6
hallmark architecture groups
209
public oncology subtype entries
BioAtlas frames oncology through 24 hallmark-level cancer intelligence datasets, with each hallmark treated as its own structured dataset rather than a generic cancer label. This allows cancer behaviour to be reviewed across identity drift, immune escape, tissue invasion, replication pressure, angiogenesis, genome instability, inflammation, metabolism, stress adaptation, and survival dynamics.
Cancer metabolism is expanded into 58 individual metabolic adaptation mechanisms, allowing BioAtlas to map how tumour states adapt energy use, nutrient routing, redox balance, biosynthesis, mitochondrial behaviour, hypoxia response, lipid handling, amino acid demand, and metabolic dependencies relevant to systems-oncology interpretation.
Programmed cell death is represented through 41 individual PCD datasets, covering how cancer alters exit signalling, immune visibility, inflammatory response patterns, stress adaptation, and regulated cellular disposal. This makes PCD intelligence central to understanding how persistence, adaptation, and cellular-removal dynamics interact across tumour systems.
Metabolic Intelligence
BioAtlas links tumour energy pressure, glycolysis, glutamine logic, lipid behaviour, mitochondrial dysfunction, redox pressure, one-carbon metabolism, immune metabolism, hallmark crosswalks, programmed cell death context, and subtype overlays into a wider metabolic intelligence layer. The public oncology page introduces the bridge; the full metabolic estate is explained separately as its own public intelligence route.
58
metabolic adaptation mechanisms
11
metabolic registry domains
105
metabolic enzyme records
PCD Intelligence
BioAtlas maps 41 programmed cell death systems through six public-safe layers, PCD-cell relationships, oncology subtype context, hallmark bridges, metabolic pressure, immune visibility, tissue behaviour, and pharma-metabolic review surfaces. The oncology page keeps the bridge visible; the dedicated PCD Intelligence route explains the layer in its own right.
41
canonical PCD systems
999
PCD-cell matrix edges
1,094
pharma PCD-metabolic records
The public page explains the positioning only. Deeper target maps, subtype intelligence, drug-repurposing context, PCD matrices, synergy views, and diligence material stay gated behind reviewed access.
Immune signalling provenance
BioAtlas includes the GcMAF / Nagalase / fibrin-reduction preprint as a research provenance record for immune-signalling, macrophage activation context, microbiome-oncology interfaces, inflammatory-state interpretation, and systems-biology review. This is included for research mapping and provenance only, not as treatment instruction, dosing guidance, diagnosis, or clinical recommendation.
Open GcMAF preprint recordRelevant public papers
These papers show the earlier research pathway behind the oncology estate. They were written through a strong ECS modulation lens, including the earlier hallmark framing and exploratory ECS-signalling interpretations across programmed cell death pathways. The current BioAtlas datasets now extend beyond that paper layer into systems biology: 24 fully mapped oncology hallmarks, 58 metabolic adaptation mechanisms, and 41 individual PCD datasets, each with mapped miRNA, enzyme, and pathway intelligence layers.
Maps 22 cancer hallmarks against ECS, signalling, and systems-biology layers for oncology intelligence.
Connects ECS modulation with programmed cell-death classes and cell-fate systems interpretation.
A systems oncology research record around systems-level cancer interpretation and AI-supported oncology intelligence.
Frames metabolic reprogramming as a core systems-biology and oncology intelligence layer.
An oncology research record connecting OV context, nutrigenetics, microbiome, frequency, and enzyme-driven systems framing.
Research provenance record connecting GcMAF, Nagalase suppression, fibrin context, macrophage activation discussion, immune signalling, and systems-biology review boundaries.
Connects ECS signalling with tumour microenvironment behaviour, immune evasion, and apoptosis context.
Positions ECS dysregulation as a systems-level failure of biological coordination across cancer hallmarks.
Links cancer hallmark logic with programmed cell-death coordination and endocannabinoid signalling.
Frames persistent signalling and drug resistance as a compartmental redistribution problem rather than a single-pathway failure.
Connects proton tunnelling, base-pair instability, epigenetic collapse, and oncogenesis as a systems biology research thread.
These records are included for provenance, publication, and review context only. They do not create medical advice, treatment instruction, dosing guidance, autonomous decision-making, or clinical access.
Oncology material can support research, diligence, licensing, and strategic review, but the deeper estate is intentionally protected.
Request reviewed access